Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
496 people get NUVA articles and Market Currents by email alert.
Get email alerts on NUVA »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Marketwire (May 6, 2013)
-
Marketwire (May 1, 2013)
-
Marketwire (Apr 30, 2013)
-
Marketwire (Apr 24, 2013)
-
Marketwire (Apr 16, 2013)
-
Marketwire (Apr 11, 2013)
-
Marketwire (Mar 27, 2013)
-
Marketwire (Mar 19, 2013)
-
-
Marketwire (Feb 26, 2013)
-
Marketwire (Feb 26, 2013)
-
-
-
Marketwire (Feb 19, 2013)
-
Marketwire (Feb 7, 2013)
-
Marketwire (Feb 5, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
NuVasive: Earnings Miss, A Risk Or An Opportunity?Kapitall • Thu, Oct 4, 2012 -
-
-
-
-
-
NuVasive: Momentum Breeds MomentumTraderMark • Tue, Jun 23, 2009 -
NuVasive: Not for the Faint of HeartTraderMark • Mon, Apr 27, 2009
-
Even in a Depression, We'll Need NuVasiveTraderMark • Thu, Nov 20, 2008
-
Investors Business Daily on NuVasiveTraderMark • Tue, Nov 4, 2008
-
Expect Big Things from NuvasiveDouglas Cress • Mon, Mar 10, 2008
-
-
-
-
-
-
-
-
-
-
-
Earnings Preview: Stryker CorporationVytautas Drumelis • Tue, Jul 17, 2012 -
-
-
Earnings Preview: AngioDynamicsVytautas Drumelis • Thu, Jul 5, 2012
-
-
-
4 Outperforming Healthcare Stocks With Strong Sales TrendsKapitall • Sun, May 13, 2012
-
-
Review Of Analyst Upgrades This Week - Part IVThe Value Investor • Mon, May 7, 2012
-
Biotechnology And Drugs Stocks To Watch For Next WeekStockPandit • Wed, Apr 25, 2012
-
NuVasive's CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Oct 24, 2012 • 1 Comment
-
NuVasive Management Discusses Q2 2012 Results - Earnings Call TranscriptThu, Jul 26, 2012
-
NuVasive Inc. Q3 2009 Earnings Call TranscriptTue, Oct 20, 2009
-
NuVasive, Inc., Q1 2009 Earnings Call TranscriptThu, Apr 23, 2009
-
NuVasive Inc. Q4 2008 Earnings Call TranscriptWed, Feb 25, 2009
-
NuVasive Q3 2008 Earnings Call TranscriptWed, Oct 22, 2008
-
NuVasive, Inc., Q2 2008 Earnings Call TranscriptThu, Jul 24, 2008
-
NuVasive, Inc. Q1 2008 Earnings Call TranscriptWed, Apr 23, 2008
-
NuVasive Q4 2007 Earnings Call TranscriptFri, Feb 22, 2008
-
Marketwire (May 6, 2013)
-
Marketwire (May 1, 2013)
-
Marketwire (Apr 30, 2013)
-
Marketwire (Apr 24, 2013)
-
Marketwire (Apr 16, 2013)
-
Marketwire (Apr 11, 2013)
-
Marketwire (Mar 27, 2013)
-
Marketwire (Mar 19, 2013)
-
Marketwire (Feb 26, 2013)
-
Marketwire (Feb 26, 2013)
-
Marketwire (Feb 19, 2013)
-
Marketwire (Feb 7, 2013)
-
Marketwire (Feb 5, 2013)
-
Marketwire (Jan 9, 2013)
-
Marketwire (Jan 2, 2013)
-
Marketwire (Dec 17, 2012)
-
Marketwire (Dec 13, 2012)
-
Marketwire (Dec 10, 2012)
-
Marketwire (Nov 19, 2012)
NUVA vs. ETF Alternatives
Company Description
Currently, there's no company description for NUVA.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, April 30, 4:45 PM NuVasive (NUVA): Q1 EPS of $0.26 beats by $0.04. Revenue of $159.5M (+5.2% Y/Y) beats by $2.06M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, April 30, 12:10 AM Notable earnings after Tuesday’s close: ACAS, AFFX, AJG, AMRS, APU, ATLS, AUY, AVB, BCOV, BGC, BLMN, BXP, CAVM, CLD, CRAY, DDR, DENN, DGI, DWA, EEP, EIX, ELGX, ELLI, ENTR, EQR, EZPW, FEIC, FIRE, FISV, FLEX, FMC, FTNT, GDOT, GEVO, GNW, HCBK, HT, HTCH, IACI, INT, JIVE, JLL, JMBA, LEAP, MDU, MERU, MRGE, MSPD, MTW, MWA, MX, NANO, NCR, NUVA, OKE, OKS, PRAA, PRXL, QCOR, QEP, REXX, RGC, RPXC, SGI, SHOR, SIMG, SKT, SM, SONS, STR, SWI, TE, TRMB, TRN, UGI, ULTI, UNTD, UNXL, VNR, VRSK, VRTX, WNC, WRI, WU, XCO Comment! [Earnings]
- Monday, April 29, 5:35 PM Notable earnings after Tuesday’s close: ACAS, AFFX, AJG, AMRS, APU, ATLS, AUY, AVB, BCOV, BGC, BLMN, BXP, CAVM, CLD, CRAY, DDR, DENN, DGI, DWA, EEP, EIX, ELGX, ELLI, ENTR, EQR, EZPW, FEIC, FIRE, FISV, FLEX, FMC, FTNT, GDOT, GEVO, GNW, HCBK, HT, HTCH, IACI, INT, JIVE, JLL, JMBA, LEAP, MDU, MERU, MRGE, MSPD, MTW, MWA, MX, NANO, NCR, NUVA, OKE, OKS, PRAA, PRXL, QCOR, QEP, REXX, RGC, RPXC, SGI, SHOR, SIMG, SKT, SM, SONS, STR, SWI, TE, TRMB, TRN, UGI, ULTI, UNTD, UNXL, VNR, VRSK, VRTX, WNC, WRI, WU, XCO 2 Comments [Earnings]
- Tuesday, February 26, 4:32 PM NuVasive (NUVA): Q4 EPS of $0.34 beats by $0.13. Revenue of $165.8M (+10.4% Y/Y) beats by $9.45M. Shares +3.2% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Tuesday, February 26, 12:10 AM Notable earnings after Tuesday’s close: AVGO, AWK, DGI, DWA, EIX, FSLR, GA, GPOR, GWRE, HRZN, JAZZ, MAKO, MIDD, NUVA, ORA, PCLN, QCOR, RENN, REXX, RRC, SPN, STEC, TIVO, VNO, VRSK, ZAGG Comment! [Earnings]
- Monday, February 25, 5:35 PM Notable earnings after Tuesday’s close: AVGO, AWK, DGI, DWA, EIX, FSLR, GA, GPOR, GWRE, HRZN, JAZZ, MAKO, MIDD, NUVA, ORA, PCLN, QCOR, RENN, REXX, RRC, SPN, STEC, TIVO, VNO, VRSK, ZAGG Comment! [Earnings]
- Friday, January 11, 10:39 AM Shares of Nuvasive (NUVA +3.5%) get a boost this morning from Janney Montgomery, who initiated the shares with a Buy and a price target of $22 on the back of the company's upbeat report yesterday that it expects to beat FY12 Street expectations. Comment! [Healthcare, On the Move]
- Wednesday, January 9, 9:50 AM NuVasive (NUVA) jumps 11.7% after disclosing that preliminary 2012 revenues climbed 15% to $619M, above previous guidance of $601-606M and analyst consensus of $604.4M. NuVasive expects 2013 sales of $655M vs Street forecasts of $638.16M. "We anticipate that our market share taking strategy and momentum can be sustained in 2013," says CEO Alex Lukianov, who's due to present at the JPM Healthcare conference today. (PR) Comment! [Earnings, Healthcare, On the Move]
-
Wednesday, January 9, 9:10 AM
Premarket gainers: ROSG +18%. NUVA +14%. GPN +8%. CLWR +7%. SKUL +7%.
Losers: APOL -8%. XTEX -6%. MT -5%.
Comment! [On the Move] - Thursday, December 20, 2012, 3:07 PM NuVasive (NUVA +0.7%) says the first PCM Cervical Disc surgery on a patient was performed in Orlando, Florida today. Surgeon proctors, who will instruct upcoming training courses, have started scheduling surgeries now that the new device is available. NUVA received FDA approval for the PCM Cervical Disc in October and surgeon demand for training looks healthy, with courses scheduled to begin next month. Comment! [Healthcare]
- Monday, December 17, 2012, 12:11 PM NuVasive (NUVA -0.3%) says it's received Japanese approval of its CoRoent Large Impacted and CoRoent Large Tapered titanium alloy implants. The implants are used in posterior spine fusion procedures and are NUVA's first two interbody fusion cages to be approved in Japan. Comment! [Healthcare]
- Thursday, December 13, 2012, 5:12 PM NuVasive (NUVA) says it's obtained the release of $62.5M from a restricted escrow account in relation to the reversal of a decision in it's trademark dispute regarding the NeuroVision trade name. In January 2011, an unfavorable judgment was entered against NUVA in the amount of $60M plus attorney fees and costs, for which it subsequently transferred $62.5M into a restricted escrow account to secure the judgment. The plaintiff has not appealed, thus enabling the company to secure the release of the funds. Comment! [Healthcare]
- Wednesday, October 24, 2012, 2:48 PM NuVasive (NUVA +13%) moves up after beating on its Q3 bottom and top line numbers today. The company lowers guidance going forward, now expecting FY12 revenue of between $601M to $606M on earnings of $0.88 to $0.90 per share. However, the company also noted that it's aggressively moving to replenish its diminished salesforce that led to flat third-quarter sales growth in its spinal division. 1 Comment [Healthcare, Earnings, On the Move]
- Wednesday, October 24, 2012, 7:14 AM NuVasive (NUVA): Q3 EPS of $0.23 beats by $0.02. Revenue of $148.4M (+11.7% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Thursday, October 4, 2012, 3:41 PM A host of Wall Street firms weigh in on NuVasive (NUVA -34%), cutting their ratings after the company lowered its Q3 revenue outlook late yesterday. Barclay's downgrades the shares to Equalweight, JMP to Market Perform, First Analysis to Equal Weight, Summer Street to Neutral, BMO and RBC to Underperform, and Well Fargo to Market Perform. Wells also also hacked it's price target range on the shares to $15 - $16 from $29 - $31. 1 Comment [Healthcare, Earnings, On the Move]
-
Thursday, October 4, 2012, 12:45 PM
Midday top 10 gainers: VRNG +22%. ELMD +20%. IFNY +18%. JKS +17%. BSI +17%. CHC +16%. EFUT +14%. ARQL +14%. GNK +12%. NIHD +13%.
Top 10 Losers: NUVA -33%. INFA -26%. SRPT -16%. TNGN -15%. HMSY -14%. PBM -12%. DAEG -11%. ISCA -10%. QLIK -9%. BPAX -9%. Comment! [On the Move]
-
- View all 0 replies
-
Andrew Shapiro
http://seekingalpha.com/a/lh6r Sparton Q1 FY 2013 Call Highlights Temporary Nature Of Lower Profits $SPA $FMS $GR $NOC $NUVA $PH $RTN $SI - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 4 replies
-
-
-
Jim Van Meerten
NUVA - 96% Barchart technical buy signal - 9 new highs and up 17.14% in the last month - Relative Strength Index 64.01% - View all 0 replies
-
Cockrell Group
$NUVA Larry Biegelsen at Wells Fargo initiated coverage of NuVasive with a Market Perform rating on the shares. - View all 0 replies
-
- View all 0 replies
-
Jacob Wolinsky
Sparton Reports Superb Second Quarter Results http://bit.ly/yTQ7OG $SPR $BA, $GR, $NOC, $NUVA, $PH, $RTN, $SI - View all 0 replies
-
Andrew Shapiro
http://seekingalpha.com/a/7nhj "Sparton Q2 Results Power Past Siemens Medical Speed Bump" $SPA;$SI $BA $GR $NOC, $NUVA $PH $RTN #value - View all 0 replies
LATEST REPLIES
-
- View all 4 replies
-
-